Bioactive IGF-I Concentrations in Children on GH Therapy - Top-Institutions - MDSpire

Bioactive IGF-I Concentrations in Children on GH Therapy

  • By

  • Lea Vilmann

  • Jakob Albrethsen

  • Jørgen Holm Petersen

  • Stine Agergaard Holmboe

  • Peter Christiansen

  • Katharina Maria Main

  • Line Cleemann

  • Kristian Horsman Hansen

  • Jan Frystyk

  • Casper P Hagen

  • Anders Juul

  • October 14, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Pediatric Endocrinology
    • Growth Hormone Research
    • Clinical Biochemistry

  • #2

    Boston Children's Hospital, Harvard Medical School
    Boston Children's Hospital, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Pediatric Endocrinology
    • Growth Disorders
    • Clinical Research

  • #3

    University of Copenhagen, Department of Growth and Reproduction
    University of Copenhagen, Department of Growth and Reproduction

    Copenhagen, Denmark

    Key Differentiators

    • Pediatric Endocrinology
    • Growth Hormone Research
    • Reproductive Biology

  • #4

    University of Michigan, Mott Children's Hospital
    University of Michigan, Mott Children's Hospital

    Ann Arbor, MI

    Key Differentiators

    • Pediatric Endocrinology
    • Growth Hormone Therapy
    • Clinical Biochemistry

  • #5

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Endocrinology
    • Growth Disorders
    • Translational Research

Original Source(s)

Bioactive IGF-I Concentrations in Children on GH Therapy

  • by Lea Vilmann, Jakob Albrethsen, Jørgen Holm Petersen, Stine Agergaard Holmboe, Peter Christiansen, Katharina Maria Main, Line Cleemann, Kristian Horsman Hansen, Jan Frystyk, Casper P Hagen, Anders Juul

  • October 14, 2025

Related Content

Growth hormone therapy after hematopoietic cell transplantation in childhood: a nationwide survey and longitudinal cohort study

Predictors of early response to GnRH and gonadotropin therapy in pediatric patients with suspected dual congenital hypogonadotropic hypogonadism: a retrospective single-center study

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report